{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:03Z","timestamp":1792801983832,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alzheimer\u2019s Research UK small grant","award":["ARUK AVR01961"],"award-info":[{"award-number":["ARUK AVR01961"]}],"id":[{"id":"https:\/\/ror.org\/02ymzm013","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000627","name":"Guarantors of Brain","doi-asserted-by":"publisher","award":["Clinical Post Doctoral Fellowship"],"award-info":[{"award-number":["Clinical Post Doctoral Fellowship"]}],"id":[{"id":"10.13039\/501100000627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neuronal and glial cytoplasmic inclusions positive for TAR DNA-binding protein 43 (TDP-43) are the defining pathological hallmark of 97% of amyotrophic lateral sclerosis (ALS) and 50% of frontotemporal dementia (FTD). The ALS-FTD clinicopathological spectrum variably involves cortical and spinal anterior horn cell pathology. The broader protein composition of these inclusions is of major importance to understanding pathogenesis, clinical heterogeneity and biomarker development. This study examined the proteome associated with TDP-43 inclusions in ALS, using mass spectrometry-based proteomic analysis of spinal cord and cerebral cortex from donors with phosphoTDP-43 positive ALS (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200916), alpha-synuclein positive Parkinson\u2019s disease (PD,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098), phosphotau and beta-amyloid positive Alzheimer\u2019s disease (AD,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098) and age matched non-neurological controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098), comparing ALS with non-ALS conditions, spinal cord with cerebral cortex samples, and detergent-soluble with -insoluble fractions. Increased abundance of TDP-43 in the detergent-insoluble fraction of ALS cortex and spinal cord tissue confirmed disease-specific protein enrichment by serial fractionation. The most striking alterations between ALS and other conditions were found in the detergent-insoluble fraction of spinal cord, with predominant enrichment of endosomal and extracellular vesicle pathways. In the cortex mitochondrial membrane\/envelope and ion transmembrane transport pathways were enriched in the detergent-insoluble fraction. RNA\/DNA metabolic processes (in spinal cord) versus mitochondrial and synaptic protein pathways (in cortex) were upregulated in the detergent-soluble fraction of ALS cases and downregulated in the insoluble protein fraction. Whilst motor cortex and spinal cord may not optimally reflect disease-specific pathways in AD, in PD a significant enrichment of alpha-synuclein in the detergent-insoluble fraction of spinal cord was found. Among proteins concordantly elevated in the detergent-insoluble fractions of spinal cord and cortex, there was greater representation of proteins encoded by ALS-associated genes, specifically Cu\/Zn superoxide dismutase 1, valosin containing protein and TDP-43 (odds ratio 16.34,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002). No significant increase in TDP-43 interacting proteins was observed in either detergent-soluble or -insoluble fractions. Together, this study shows a divergence in the composition of proteins associated with TDP-43 positive detergent-insoluble inclusions between spinal cord and cerebral cortex. A common upregulation of proteins encoded by ALS-causing genes implicates their role in the pathogenesis of the ALS-FTD spectrum of diseases beyond TDP-43. Data are available via ProteomeXchange with identifier PXD067060.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-02084-y","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T04:28:32Z","timestamp":1755491312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord"],"prefix":"10.1186","volume":"13","author":[{"given":"Emily","family":"Feneberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Ansorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2084_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fncel.2019.00175","volume":"13","author":"NP Alza","year":"2019","unstructured":"Alza NP, Iglesias Gonzalez PA, Conde MA, Uranga RM, Salvador GA (2019) Lipids at the crossroad of alpha-Synuclein function and dysfunction: biological and pathological implications. Front Cell Neurosci 13:175. https:\/\/doi.org\/10.3389\/fncel.2019.00175","journal-title":"Front Cell Neurosci"},{"key":"2084_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash PE, Bieniek KF, Gendron TF et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron 77:639\u2013646. https:\/\/doi.org\/10.1016\/j.neuron.2013.02.004","journal-title":"Neuron"},{"key":"2084_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41582-024-00961-z","volume":"20","author":"M Benatar","year":"2024","unstructured":"Benatar M, Wuu J, Huey ED et al (2024) The Miami framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology. Nat Rev Neurol 20:364\u2013376. https:\/\/doi.org\/10.1038\/s41582-024-00961-z","journal-title":"Nat Rev Neurol"},{"key":"2084_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.neurobiolaging.2007.08.009","volume":"30","author":"A Bersano","year":"2009","unstructured":"Bersano A, Del Bo R, Lamperti C et al (2009) Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol Aging 30:752\u2013758. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.08.009","journal-title":"Neurobiol Aging"},{"key":"2084_CR5","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1038\/s41467-024-49196-y","volume":"15","author":"L Caldi Gomes","year":"2024","unstructured":"Caldi Gomes L, Hanzelmann S, Hausmann F et al (2024) Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target. Nat Commun 15:4893. https:\/\/doi.org\/10.1038\/s41467-024-49196-y","journal-title":"Nat Commun"},{"key":"2084_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, Ozdemir S, Fritz C et al (2024) Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med 30:1771\u20131783. https:\/\/doi.org\/10.1038\/s41591-024-02937-4","journal-title":"Nat Med"},{"key":"2084_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-023-00639-y","volume":"18","author":"S Chu","year":"2023","unstructured":"Chu S, Xie X, Payan C, Stochaj U (2023) Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. Mol Neurodegener 18:52. https:\/\/doi.org\/10.1186\/s13024-023-00639-y","journal-title":"Mol Neurodegener"},{"key":"2084_CR8","doi-asserted-by":"publisher","first-page":"653688","DOI":"10.3389\/fncel.2021.653688","volume":"15","author":"R Dafinca","year":"2021","unstructured":"Dafinca R, Barbagallo P, Talbot K (2021) The role of mitochondrial dysfunction and ER stress in TDP-43 and C9ORF72 ALS. Front Cell Neurosci 15:653688. https:\/\/doi.org\/10.3389\/fncel.2021.653688","journal-title":"Front Cell Neurosci"},{"key":"2084_CR9","doi-asserted-by":"publisher","first-page":"fcae350","DOI":"10.1093\/braincomms\/fcae350","volume":"6","author":"R Dafinca","year":"2024","unstructured":"Dafinca R, Tosat-Bitrian C, Carroll E et al (2024) Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons. Brain Commun 6:fcae350. https:\/\/doi.org\/10.1093\/braincomms\/fcae350","journal-title":"Brain Commun"},{"key":"2084_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neulet.2018.04.053","volume":"678","author":"SA Davis","year":"2018","unstructured":"Davis SA, Itaman S, Khalid-Janney CM, Sherard JA, Dowell JA, Cairns NJ, Gitcho MA (2018) TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci Lett 678:8\u201315. https:\/\/doi.org\/10.1016\/j.neulet.2018.04.053","journal-title":"Neurosci Lett"},{"key":"2084_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic parkinson\u2019s disease. Acta Neuropathol 124:643\u2013664. https:\/\/doi.org\/10.1007\/s00401-012-1028-y","journal-title":"Acta Neuropathol"},{"key":"2084_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/21678421.2016.1245757","volume":"18","author":"J Engelen-Lee","year":"2017","unstructured":"Engelen-Lee J, Blokhuis AM, Spliet WGM et al (2017) Proteomic profiling of the spinal cord in ALS: decreased ATP5D levels suggest synaptic dysfunction in ALS pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener 18:210\u2013220. https:\/\/doi.org\/10.1080\/21678421.2016.1245757","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2084_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1083\/jcb.201504057","volume":"211","author":"MS Feiler","year":"2015","unstructured":"Feiler MS, Strobel B, Freischmidt A et al (2015) TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol 211:897\u2013911. https:\/\/doi.org\/10.1083\/jcb.201504057","journal-title":"J Cell Biol"},{"key":"2084_CR14","doi-asserted-by":"publisher","unstructured":"Feneberg E, Gordon D, Thompson AG, Finelli MJ, Dafinca R, Candalija A et al (2020) An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol Dis 144:105050. https:\/\/doi.org\/10.1016\/j.nbd.2020.105050. Accession Number: 32800996","DOI":"10.1016\/j.nbd.2020.105050"},{"key":"2084_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E, Steinacker P, Lehnert S et al (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener 15:351\u2013356. https:\/\/doi.org\/10.3109\/21678421.2014.905606","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2084_CR16","doi-asserted-by":"publisher","first-page":"e12923","DOI":"10.1111\/bpa.12923","volume":"31","author":"E Feneberg","year":"2021","unstructured":"Feneberg E, Charles PD, Finelli MJ et al (2021) Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP. Brain Pathol 31:e12923. https:\/\/doi.org\/10.1111\/bpa.12923","journal-title":"Brain Pathol"},{"key":"2084_CR17","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1073\/pnas.1914670117","volume":"117","author":"JK Hannestad","year":"2020","unstructured":"Hannestad JK, Rocha S, Agnarsson B, Zhdanov VP, Wittung-Stafshede P, Hook F (2020) Single-vesicle imaging reveals lipid-selective and Stepwise membrane disruption by monomeric alpha-synuclein. Proc Natl Acad Sci U S A 117:14178\u201314186. https:\/\/doi.org\/10.1073\/pnas.1914670117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2084_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","volume":"173","author":"LM Igaz","year":"2008","unstructured":"Igaz LM, Kwong LK, Xu Y et al (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal Lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173:182\u2013194. https:\/\/doi.org\/10.2353\/ajpath.2008.080003","journal-title":"Am J Pathol"},{"key":"2084_CR19","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi Y, Eid L, Parent M et al (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139:3187\u20133201. https:\/\/doi.org\/10.1093\/brain\/aww237","journal-title":"Brain"},{"key":"2084_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson JO, Mandrioli J, Benatar M et al (2010) Exome sequencing reveals VCP mutations as a cause of Familial ALS. Neuron 68:857\u2013864. https:\/\/doi.org\/10.1016\/j.neuron.2010.11.036","journal-title":"Neuron"},{"key":"2084_CR21","doi-asserted-by":"publisher","unstructured":"julian.knight@well.ox.ac.uk CO-M-oBACEa, Consortium CO-M-oBA (2022) A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185: 916\u2013938 e958. https:\/\/doi.org\/10.1016\/j.cell.2022.01.012","DOI":"10.1016\/j.cell.2022.01.012"},{"key":"2084_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1074\/mcp.M114.041012","volume":"14","author":"EC Keilhauer","year":"2015","unstructured":"Keilhauer EC, Hein MY, Mann M (2015) Accurate protein complex retrieval by affinity enrichment mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS). Mol Cell Proteom 14:120\u2013135. https:\/\/doi.org\/10.1074\/mcp.M114.041012","journal-title":"Mol Cell Proteom"},{"key":"2084_CR23","doi-asserted-by":"publisher","first-page":"120753","DOI":"10.1016\/j.jns.2023.120753","volume":"452","author":"A Lee","year":"2023","unstructured":"Lee A, Henderson R, Arachchige BJ, Robertson T, McCombe PA (2023) Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms. J Neurol Sci 452:120753. https:\/\/doi.org\/10.1016\/j.jns.2023.120753","journal-title":"J Neurol Sci"},{"key":"2084_CR24","doi-asserted-by":"publisher","unstructured":"Liu G, Coyne AN, Pei F, Vaughan S, Chaung M, Zarnescu DC, Buchan JR (2017) Endocytosis regulates TDP-43 toxicity and turnover. Nat Commun 8: 2092. https:\/\/doi.org\/10.1038\/s41467-017-02017-x","DOI":"10.1038\/s41467-017-02017-x"},{"key":"2084_CR25","doi-asserted-by":"publisher","unstructured":"Lucini CB, Braun RJ (2021) Mitochondrion-Dependent cell death in TDP-43 proteinopathies. Biomedicines 9. https:\/\/doi.org\/10.3390\/biomedicines9040376","DOI":"10.3390\/biomedicines9040376"},{"key":"2084_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00401-020-02252-5","volume":"141","author":"AR Mehta","year":"2021","unstructured":"Mehta AR, Gregory JM, Dando O et al (2021) Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis. Acta Neuropathol 141:257\u2013279. https:\/\/doi.org\/10.1007\/s00401-020-02252-5","journal-title":"Acta Neuropathol"},{"key":"2084_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz099","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain: Doi. https:\/\/doi.org\/10.1093\/brain\/awz099","journal-title":"Brain: Doi"},{"key":"2084_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal Lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133 Doi 314\/5796\/130 [pii]. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"2084_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","volume":"139","author":"P Oeckl","year":"2020","unstructured":"Oeckl P, Weydt P, Thal DR, Weishaupt JH, Ludolph AC, Otto M (2020) Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol 139:119\u2013134. https:\/\/doi.org\/10.1007\/s00401-019-02093-x","journal-title":"Acta Neuropathol"},{"key":"2084_CR301","doi-asserted-by":"publisher","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, John NS, Prakash A, Walzer M, Wang S, Vizca\u00edno JA (2025) The PRIDE database at 20 years: 2025 update. Nucleic Acids Res 53(D1):D543\u2013D553. https:\/\/doi.org\/10.1093\/nar\/gkae1011. (PubMed ID: 39494541)","DOI":"10.1093\/nar\/gkae1011"},{"key":"2084_CR30","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J et al (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47:D442\u2013D450. https:\/\/doi.org\/10.1093\/nar\/gky1106","journal-title":"Nucleic Acids Res"},{"key":"2084_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/08923973.2019.1650371","volume":"41","author":"C Porro","year":"2019","unstructured":"Porro C, Panaro MA, Lofrumento DD, Hasalla E, Trotta T (2019) The multiple roles of exosomes in parkinson\u2019s disease: an overview. Immunopharmacol Immunotoxicol 41:469\u2013476. https:\/\/doi.org\/10.1080\/08923973.2019.1650371","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2084_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40478-022-01487-5","volume":"10","author":"A Raunio","year":"2022","unstructured":"Raunio A, Kivisto V, Kero M et al (2022) Distribution of Lewy-related pathology in the brain, spinal cord, and periphery: the population-based Vantaa 85\u2009+\u2009study. Acta Neuropathol Commun 10:178. https:\/\/doi.org\/10.1186\/s40478-022-01487-5","journal-title":"Acta Neuropathol Commun"},{"key":"2084_CR33","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.15252\/embj.201694221","volume":"35","author":"BM Schwenk","year":"2016","unstructured":"Schwenk BM, Hartmann H, Serdaroglu A et al (2016) TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons. EMBO J 35:2350\u20132370. https:\/\/doi.org\/10.15252\/embj.201694221","journal-title":"EMBO J"},{"key":"2084_CR34","doi-asserted-by":"publisher","first-page":"13023","DOI":"10.1074\/jbc.M110.204776","volume":"286","author":"VV Shvadchak","year":"2011","unstructured":"Shvadchak VV, Falomir-Lockhart LJ, Yushchenko DA, Jovin TM (2011) Specificity and kinetics of alpha-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe. J Biol Chem 286:13023\u201313032. https:\/\/doi.org\/10.1074\/jbc.M110.204776","journal-title":"J Biol Chem"},{"key":"2084_CR35","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1016\/j.celrep.2020.02.078","volume":"30","author":"Sleigh","year":"2020","unstructured":"Sleigh JN, Tosolini AP, Gordon D, Devoy A, Fratta P, Fisher EMC, Talbot K, Schiavo G (2020) Mice carrying ALS mutant TDP-43, but not mutant FUS, display in vivo defects in axonal transport of signaling endosomes. Cell Rep 30:3655\u20133662. e3652. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.078","journal-title":"Cell Rep"},{"key":"2084_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","volume":"12","author":"AG Thompson","year":"2016","unstructured":"Thompson AG, Gray E, Heman-Ackah SM, Mager I, Talbot K, Andaloussi SE, Wood MJ, Turner MR (2016) Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol 12:346\u2013357. https:\/\/doi.org\/10.1038\/nrneurol.2016.68","journal-title":"Nat Rev Neurol"},{"key":"2084_CR37","doi-asserted-by":"publisher","first-page":"642324","DOI":"10.3389\/fnins.2021.642324","volume":"15","author":"AG Thompson","year":"2021","unstructured":"Thompson AG, Gray E, Charles PD, Hu MTM, Talbot K, Fischer R, Kessler BM, Turner MR (2021) Network analysis of the CSF proteome characterizes convergent pathways of cellular dysfunction in ALS. Front Neurosci 15:642324. https:\/\/doi.org\/10.3389\/fnins.2021.642324","journal-title":"Front Neurosci"},{"key":"2084_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40478-022-01421-9","volume":"10","author":"BG Trist","year":"2022","unstructured":"Trist BG, Fifita JA, Hogan A et al (2022) Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration. Acta Neuropathol Commun 10:122. https:\/\/doi.org\/10.1186\/s40478-022-01421-9","journal-title":"Acta Neuropathol Commun"},{"key":"2084_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh ME, Dammer EB, Dai J et al (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10:48\u201362. https:\/\/doi.org\/10.15252\/emmm.201708202","journal-title":"EMBO Mol Med"},{"key":"2084_CR40","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/15548627.2015.1084460","volume":"11","author":"Y Xie","year":"2015","unstructured":"Xie Y, Zhou B, Lin MY, Sheng ZH (2015) Progressive endolysosomal deficits impair autophagic clearance beginning at early asymptomatic stages in fALS mice. Autophagy 11:1934\u20131936. https:\/\/doi.org\/10.1080\/15548627.2015.1084460","journal-title":"Autophagy"},{"key":"2084_CR41","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y et al (2024) Using clusterprofiler to characterize multiomics data. Nat Protoc 19:3292\u20133320. https:\/\/doi.org\/10.1038\/s41596-024-01020-z","journal-title":"Nat Protoc"},{"key":"2084_CR42","doi-asserted-by":"publisher","unstructured":"Yu CH, Davidson S, Harapas CR et al (2020) TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS. Cell 183: 636\u2013649 e618. https:\/\/doi.org\/10.1016\/j.cell.2020.09.020","DOI":"10.1016\/j.cell.2020.09.020"},{"key":"2084_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-022-00532-0","volume":"17","author":"J Zhu","year":"2022","unstructured":"Zhu J, Pittman S, Dhavale D et al (2022) VCP suppresses proteopathic seeding in neurons. Mol Neurodegener 17:30. https:\/\/doi.org\/10.1186\/s13024-022-00532-0","journal-title":"Mol Neurodegener"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02084-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T04:28:33Z","timestamp":1755491313000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02084-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02084-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Donors had provided written informed consent for brain donation and the use of the material and clinical information for research purposes under Research Ethics Committee approval (REC 15\/SC\/0639, HTA license 12217).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}